About the Authors
- Molly E. Zimmerman
-
* E-mail: mzimmerman7@fordham.edu
Affiliations Department of Psychology, Fordham University, Bronx, New York, United States of America, Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Ali Ezzati
-
Affiliation Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Mindy J. Katz
-
Affiliation Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Michael L. Lipton
-
Affiliations Department of Radiology, Albert Einstein College of Medicine, Bronx, New York, United States of America, Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, United States of America, Gruss Magnetic Resonance Research Center, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Adam M. Brickman
-
Affiliation Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, New York, United States of America
- Martin J. Sliwinski
-
Affiliation Department of Human Development and Family Studies, Pennsylvania State University, University Park, Pennsylvania, United States of America
- Richard B. Lipton
-
Affiliations Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, United States of America, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, United States of America, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York, United States of America
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: RBL receives research support from the NIH: PO1 AG003949 (Program Director), PO1AG027734 (Project Leader), RO1AG025119 (Investigator), RO1AG022374-06A2 (Investigator), RO1AG034119 (Investigator), RO1AG12101 (Investigator), 23NS05140901A1 (Mentor), and K23NS47256 (Mentor), and the National Headache Foundation; serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache, has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics (a company without commercial products); serves as consultant, advisory board member, or has received honoraria from: Alder, Allergan, American Headache Society, Autonomic Technologies, Avanir, Boehringer-Ingelheim, Boston Scientific, Bristol Myers Squibb, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, Informa, Merck, Novartis, Pfizer, Teva, Vedanta. MEZ, MJK, and MLL are co-investigators on NIH P01 AG003949; they have no additional conflicts of interest. AE, AMB, and MJS have no competing interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MEZ AE MJK MLL AMB MJL RBL. Performed the experiments: MEZ AE MJK MLL AMB MJL RBL. Analyzed the data: MEZ AE MJK MLL AMB MJL RBL. Contributed reagents/materials/analysis tools: MEZ AE MJK MLL AMB MJL RBL. Wrote the paper: MEZ AE MJK MLL AMB MJL RBL.